Kendle
From Wikipedia, the free encyclopedia
 |
This article or section is missing citations or needs footnotes. Using inline citations helps guard against copyright violations and factual inaccuracies. (November 2007) |
| Kendle International, Inc. | |
|---|---|
| Type | Public (NASDAQ: KNDL) |
| Founded | 1981 |
| Headquarters | Cincinnati, Ohio |
| Key people | Candace Kendle, PharmD, Chairman and CEO Christopher C. Bergen, COO Simon Higginbotham, President Karl "Buzz" Brenkert, CFO Alan Boyce, VP & CMO |
| Industry | Contract Research Organizations Pharmaceutical |
| Products | drug development services |
| Website | www.kendle.com |
Kendle International, Inc. (Nasdaq:KNDL) is a contract research organization, (also known as a clinical research organization), involved in the conduct of clinical trials worldwide. Kendle International Inc. was founded in 1981 by Chairman and CEO Candace Kendle, PharmD and COO Chris Bergen. To date, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in 90 countries.
 |
This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |
